Pure Global AI
ABMed Décret

Décret 2024-1300 du 6 novembre 2024

Autorisation et supervision des essais cliniques
BeninAgence béninoise du Médicament et des autres produits de SantéClinical TrialsEffective 2024-11-06
Official source linked
What this code is

Décret 2024-1300 du 6 novembre 2024 is the official ABMed identifier for “Autorisation et supervision des essais cliniques”. Décret 2024-1300 du 6 novembre 2024 is the official identifier ABMed uses for this instrument.

Instrument
Décret
Full name
Décret 2024-1300 du 6 novembre 2024
Category
Clinical Trials
Source links
Source publication
French
Open the source text
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Read the full text →
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
2024-11-06
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

French full textFrench — original textRead HTML →
About this regulation

Autorisation et supervision des essais cliniques

Complete eleven-article Presidential decree and signatures, five physical pages, governing clinical trials of health products. Requires local representation for foreign sponsors, dossier review, technical and ethics assessments, authorisation, supervision and changes. The separate implementing clinical guidelines remain distinct documents.

Décret 2024-1300 du 6 novembre 2024 is the official identifier ABMed uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.

Source linked